Propranolol Hydrochloride
- Product NDC
- 42689-012
- 11-digit product format
- 426890012
- Labeler code
- 42689
- Product ID
- 42689-012_81548a65-4cc7-4e02-9846-590737a74469
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Propranolol Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Nortec Development Associates, Inc
- Application
- ANDA078065
- Marketing category
- ANDA
- Marketing start
- 2015-05-01
- Marketing end
- 0000-00-00
- Substance
- PROPRANOLOL HYDROCHLORIDE
- Active strength
- 80 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42689-012-01 | Propranolol Hydrochloride | 100 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 100 | | 5 |
| 42689-012-10 | Propranolol Hydrochloride | 1000 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 1000 | | 5 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Propranolol Hydrochloride | ACTIVE INGREDIENT | F8A3652H1V | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 1 | |
| PROPRANOLOL | ACTIVE MOIETY | 9Y8NXQ24VQ | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 1 | |
| ETHYLCELLULOSE (45 MPA.S) | INACTIVE INGREDIENT | V7AD894FAZ | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 1 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 1 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 1 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 1 | |
| HYPROMELLOSE 2910 (5 MPA.S) | INACTIVE INGREDIENT | R75537T0T4 | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42689-012 | PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE [NORTEC DEVELOPMENT ASSOCIATES, INC] | 5 | Legacy NDC, 2 package rows | 20241204_b756f602-62c9-41ef-a934-834ac81b46ae.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42689-012-01 | 42689001201 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42689-012-01) | 2015-05-01 | 0000-00-00 | No | No | Current |
| 42689-012-10 | 42689001210 | 1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42689-012-10) | 2015-05-01 | 0000-00-00 | No | No | Current |